Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Step by step instructions to Choose the Right Internet based Degree Program for Your Future - 2Step by step instructions to Pick an Incineration Urn: Variables to Consider
- 3Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space
- 41,000-mile Saharan dust storm, from the sky and from the ground
- 5Revealing the Specialty of Food Matching: Improving Culinary Encounters
- Climate engineering would alter the oceans, reshaping marine life – our new study examines each method’s risks
- 2025 Arctic League telethon raises more than $39k
- Grasping Various Kinds of Local misdemeanors
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
- Brilliant and Gleaming: Excellence and Skincare Practices
- Overlooked infertility care should be part of national health services, says WHO
- Avoid This Common Mistake When Planning Sightseeing Activities For Your Trip To Italy
- A definitive Handbook for Securities exchange Money management
- Blood pressure drug recalled for possible cross-contamination
